Sprague Brian L, Gangnon Ronald E, Hampton John M, Egan Kathleen M, Titus Linda J, Kerlikowske Karla, Remington Patrick L, Newcomb Polly A, Trentham-Dietz Amy
Am J Epidemiol. 2015 Jun 15;181(12):956-69. doi: 10.1093/aje/kwu474. Epub 2015 May 5.
Concerns about breast cancer overdiagnosis have increased the need to understand how cancers detected through screening mammography differ from those first detected by a woman or her clinician. We investigated risk factor associations for invasive breast cancer by method of detection within a series of case-control studies (1992-2007) carried out in Wisconsin, Massachusetts, and New Hampshire (n=15,648 invasive breast cancer patients and 17,602 controls aged 40-79 years). Approximately half of case women reported that their cancer had been detected by mammographic screening and half that they or their clinician had detected it. In polytomous logistic regression models, parity and age at first birth were more strongly associated with risk of mammography-detected breast cancer than with risk of woman/clinician-detected breast cancer (P≤0.01; adjusted for mammography utilization). Among postmenopausal women, estrogen-progestin hormone use was predominantly associated with risk of woman/clinician-detected breast cancer (odds ratio (OR)=1.49, 95% confidence interval (CI): 1.29, 1.72), whereas obesity was predominantly associated with risk of mammography-detected breast cancer (OR=1.72, 95% CI: 1.54, 1.92). Among regularly screened premenopausal women, obesity was not associated with increased risk of mammography-detected breast cancer (OR=0.99, 95% CI: 0.83, 1.18), but it was associated with reduced risk of woman/clinician-detected breast cancer (OR=0.53, 95% CI: 0.43, 0.64). These findings indicate important differences in breast cancer risk factors according to method of detection.
对乳腺癌过度诊断的担忧增加了了解通过乳腺钼靶筛查检测出的癌症与女性或其临床医生首次检测出的癌症有何不同的必要性。我们在威斯康星州、马萨诸塞州和新罕布什尔州开展的一系列病例对照研究(1992 - 2007年)中,按检测方法调查了浸润性乳腺癌的危险因素关联(n = 15648例浸润性乳腺癌患者和17602名年龄在40 - 79岁的对照)。大约一半的病例女性报告称其癌症是通过乳腺钼靶筛查检测出的,另一半则称是她们自己或其临床医生检测出的。在多分类逻辑回归模型中,产次和初产年龄与乳腺钼靶检测出的乳腺癌风险的关联比与女性/临床医生检测出的乳腺癌风险的关联更强(P≤0.01;经乳腺钼靶使用情况调整)。在绝经后女性中,雌激素 - 孕激素激素使用主要与女性/临床医生检测出的乳腺癌风险相关(优势比(OR)= 1.49,95%置信区间(CI):1.29,1.72),而肥胖主要与乳腺钼靶检测出的乳腺癌风险相关(OR = 1.72,95% CI:1.54,1.92)。在定期接受筛查的绝经前女性中,肥胖与乳腺钼靶检测出的乳腺癌风险增加无关(OR = 0.99,95% CI:0.83,1.18),但与女性/临床医生检测出的乳腺癌风险降低相关(OR = 0.53,95% CI:0.43,0.64)。这些发现表明,根据检测方法不同,乳腺癌危险因素存在重要差异。